Covid-19 across world: WHO recommends 2 new drugs
As the Omicron variant of coronavirus becomes dominant across the world, a World Health Organization (WHO) panel recommended the use of two more drugs to treat Covid-19. Meanwhile, Pfizer Inc said it has applied for Japanese government approval for its oral Covid-19 treatment. Also, Polish scientists said they have found a gene that more than doubles the risk of becoming severely ill with Covid-19. A World Health Organization (WHO) panel recommended the use of two drugs by Eli Lilly, and GlaxoSmithKline and Vir Biotechnology for Covid-19 patients, adding treatment options as the fast-spreading Omicron variant renders many ineffective. On Thursday, the panel recommended Lilly's baricitinib, sold under brand name Olumiant, for patients with severe Covid-19 in combination with corticosteroids. Also, it conditionally endorsed GSK-Vir's antibody therapy for non-severe patients at the highest risk of hospitalisation.